Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

p53 gene mutation in thyroid carcinoma

Y S Ho1, S C Tseng, T Y Chin

  • 1Department of Pathology, Chang-Gung Memorial Hospital, Taipei, Taiwan, ROC.

Cancer Letters
|May 15, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[A case of high-pressure injection injury of hand complicated with deep chemical burn caused by industrial cement].

Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases·2024
Same author

An OLTAM system for analysis of brown/beige fat thermogenic activity.

International journal of obesity (2005)·2018
Same author

In situ growth of carbon nanotubes on Ni/MgO: a facile preparation of efficient catalysts for the production of synthetic natural gas from syngas.

Chemical communications (Cambridge, England)·2015
Same author

Transcriptional control of circadian metabolic rhythms in the liver.

Diabetes, obesity & metabolism·2015
Same author

Associations between genetic variants and the severity of metabolic syndrome in subjects with type 2 diabetes.

Genetics and molecular research : GMR·2015
Same author

Abscisic-acid-stimulated rooting of stem cuttings.

Planta·2014
Same journal

An IL-15 fusion with albumin-binding domain boosts Immunotherapy therapy in glioblastoma via FGF-2 competition regulating FGFR1/2.

Cancer letters·2026
Same journal

Stress-adapted cancer-associated fibroblasts as mediators of immunosuppression and therapy resistance.

Cancer letters·2026
Same journal

Aldo-keto Reductase Family 1 Member C3 Suppresses Glioma Progression via Inhibiting Prostaglandin D2-Dependent RhoA/ROCK Signaling.

Cancer letters·2026
Same journal

Immunotherapy-based combination remodels the immunosuppressive microenvironment and enhances efficacy in advanced SMARCA4-deficient non-small cell lung cancer.

Cancer letters·2026
Same journal

Early-onset lung cancer: etiologic heterogeneity, genomic features, and age-informed clinical management.

Cancer letters·2026
Same journal

Talazoparib engages innate immune activation via PARP trapping-dependent cGAS/STING activation in Ewing Sarcoma.

Cancer letters·2026
See all related articles

p53 protein nuclear staining indicates aggressive thyroid cancer (poorly differentiated and undifferentiated carcinoma), while cytoplasmic staining suggests a better prognosis. p53 gene mutations are linked to aggressive subtypes, but not solely sufficient as a prognostic marker.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Thyroid carcinoma encompasses various histological subtypes with differing prognoses.
  • The p53 protein's role and mutation status are critical in cancer development and progression.
  • Understanding p53 expression patterns can aid in predicting thyroid tumor behavior.

Purpose of the Study:

  • To investigate the correlation between p53 protein expression patterns (cytoplasmic vs. nuclear) and histological subtypes of thyroid carcinoma.
  • To determine the frequency and spectrum of p53 gene mutations across different thyroid carcinoma subtypes.
  • To evaluate the prognostic significance of p53 expression and mutation in thyroid cancer.

Main Methods:

  • Analysis of p53 protein expression (cytoplasmic and nuclear staining) in 92 thyroid carcinoma cases.

Related Experiment Videos

  • Genotyping of p53 in tumor samples to identify mutations.
  • Correlation of p53 expression and mutation status with histological subtypes and clinical outcomes.

    • Main Results:

    • Nuclear p53 staining was significantly higher in poorly differentiated carcinoma (PDC) and undifferentiated carcinoma (UDC) compared to other subtypes.
    • Cytoplasmic p53 staining was associated with a more favorable prognosis.
    • Overall p53 mutation frequency was 8.5%, with higher rates in PDC (17.2%) and oncocytic carcinoma (16.7%). Missense and silent mutations were identified in exon 8.

    Conclusions:

    • Nuclear p53 positivity may serve as a marker for aggressive thyroid carcinomas (PDC, UDC).
    • p53 gene aberrations and overexpression of mutant p53 protein are crucial in aggressive thyroid cancer subtypes.
    • p53 point mutations alone are insufficient as prognostic markers for aggressive thyroid tumors; other factors may drive UDC aggressiveness.